Literature DB >> 32691835

A Critical Analysis of the Literature on Time-to-Antibiotics in Suspected Sepsis.

Jeremy Weinberger1,2, Chanu Rhee1,2, Michael Klompas1,2.   

Abstract

The Surviving Sepsis Campaign recommends immediate antibiotics for all patients with suspected sepsis and septic shock, ideally within 1 hour of recognition. Immediate antibiotic treatment is lifesaving for some patients, but a substantial fraction of patients initially diagnosed with sepsis have noninfectious conditions. Aggressive time-to-antibiotic targets risk promoting antibiotic overuse and antibiotic-associated harms for this subset of the population. An accurate understanding of the precise relationship between time-to-antibiotics and mortality for patients with possible sepsis is therefore critical to finding the best balance between assuring immediate antibiotics for those patients who truly need them versus allowing clinicians some time for rapid investigation to minimize the risk of overtreatment and antibiotic-associated harms for patients who are not infected. More than 30 papers have been published assessing the relationship between time-to-antibiotics and outcomes, almost all of which are observational cohort studies. Most report significant associations but all have important limitations. Key limitations include focusing just on the sickest subset of patients (only patients requiring intensive care and/or patients with septic shock), blending together mortality estimates from patients with very long intervals until antibiotics with patients with shorter intervals and reporting a single blended (and thus inflated) estimate for the average increase in mortality associated with each hour until antibiotics, and failure to control for large potential confounders including patients' presenting signs and symptoms and granular measures of comorbidities and severity of illness. In this study, we elaborate on these potential sources of bias and try to distill a better understanding of what the true relationship between time-to-antibiotics and mortality may be for patients with suspected sepsis or septic shock.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibiotics; quality improvement; sepsis; time-to-antibiotics

Year:  2020        PMID: 32691835     DOI: 10.1093/infdis/jiaa146

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

Review 2.  Initial antimicrobial management of sepsis.

Authors:  Michael S Niederman; Rebecca M Baron; Lila Bouadma; Thierry Calandra; Nick Daneman; Jan DeWaele; Marin H Kollef; Jeffrey Lipman; Girish B Nair
Journal:  Crit Care       Date:  2021-08-26       Impact factor: 9.097

3.  Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe).

Authors:  Jenna Jones; Susan Allen; Jan Davies; Timothy Driscoll; Gemma Ellis; Greg Fegan; Theresa Foster; Nick Francis; Saiful Islam; Matt Morgan; Prabath W B Nanayakkara; Gavin D Perkins; Alison Porter; Timothy Rainer; Samuel Ricketts; Bernadette Sewell; Tracy Shanahan; Fang Gao Smith; Michael A Smyth; Helen Snooks; Chris Moore
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.996

4.  Digital imaging for reading of direct rapid antibiotic susceptibility tests from positive blood cultures.

Authors:  Gina K Thomson; Kira Jamros; James W Snyder; Kenneth S Thomson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-25       Impact factor: 3.267

5.  Outcomes of Single-Dose Empirical Antibiotic Treatment in Children With Suspected Sepsis Implemented in the Emergency Department.

Authors:  Suwimon Khanthathasiri; Worapant Kriengsoontornkij; Apichaya Monsomboon; Wanatpreeya Phongsamart; Keswadee Lapphra; Orasri Wittawatmongkol; Supattra Rungmaitree; Kulkanya Chokephaibulkit
Journal:  Pediatr Emerg Care       Date:  2022-06-27       Impact factor: 1.602

6.  Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection.

Authors:  Jie Cheng; Qinyuan Li; Guangli Zhang; Huiting Xu; Yuanyuan Li; Xiaoyin Tian; Dapeng Chen; Zhengxiu Luo
Journal:  BMC Pediatr       Date:  2022-10-03       Impact factor: 2.567

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.